Wearable Devices: Implications for Precision Medicine and the Future of Health Care

被引:22
|
作者
Babu, Mohan [1 ]
Lautman, Ziv [1 ,2 ]
Lin, Xiangping [1 ]
Sobota, Milan H. B. [1 ]
Snyder, Michael P. [1 ]
机构
[1] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA
来源
ANNUAL REVIEW OF MEDICINE | 2024年 / 75卷
基金
美国国家卫生研究院;
关键词
wearables; longitudinal; early detection; COVID-19; precision medicine; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASES; GLOBAL BURDEN; RISK-FACTORS; HEART-RATE; ATRIAL-FIBRILLATION; INDIVIDUALS; ASSOCIATION; POPULATION; UPDATE;
D O I
10.1146/annurev-med-052422-020437
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Wearable devices are integrated analytical units equipped with sensitive physical, chemical, and biological sensors capable of noninvasive and continuous monitoring of vital physiological parameters. Recent advances in disciplines including electronics, computation, and material science have resulted in affordable and highly sensitive wearable devices that are routinely used for tracking and managing health and well-being. Combined with longitudinal monitoring of physiological parameters, wearables are poised to transform the early detection, diagnosis, and treatment/management of a range of clinical conditions. Smartwatches are the most commonly used wearable devices and have already demonstrated valuable biomedical potential in detecting clinical conditions such as arrhythmias, Lyme disease, inflammation, and, more recently, COVID-19 infection. Despite significant clinical promise shown in research settings, there remain major hurdles in translating the medical uses of wearables to the clinic. There is a clear need for more effective collaboration among stakeholders, including users, data scientists, clinicians, payers, and governments, to improve device security, user privacy, data standardization, regulatory approval, and clinical validity. This review examines the potential of wearables to offer affordable and reliable measures of physiological status that are on par with FDA-approved specialized medical devices.We briefly examine studies where wearables proved critical for the early detection of acute and chronic clinical conditions with a particular focus on cardiovascular disease, viral infections, and mental health. Finally, we discuss current obstacles to the clinical implementation of wearables and provide perspectives on their potential to deliver increasingly personalized proactive health care across a wide variety of conditions.
引用
收藏
页码:401 / 415
页数:15
相关论文
共 50 条
  • [1] Wearable Devices for Precision Medicine and Health State Monitoring
    Jeong, In Cheol
    Bychkov, David
    Searson, Peter C.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2019, 66 (05) : 1242 - 1258
  • [2] Precision Medicine and the Future of Health Care
    Twa, Michael D.
    OPTOMETRY AND VISION SCIENCE, 2017, 94 (06) : 635 - 637
  • [3] Precision Medicine, AI, and the Future of Personalized Health Care
    Johnson, Kevin B.
    Wei, Wei-Qi
    Weeraratne, Dilhan
    Frisse, Mark E.
    Misulis, Karl
    Rhee, Kyu
    Zhao, Juan
    Snowdon, Jane L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 86 - 93
  • [5] Wearable Devices in Veterinary Health Care
    Mitek, Ashley
    Jones, Dylan
    Newell, Andrew
    Vitale, Samantha
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2022, 52 (05) : 1087 - 1098
  • [6] Precision medicine: The future in diabetes care?
    Scheen, Andre J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 117 : 12 - 21
  • [7] Wearable Technology in Medicine and Health Care
    Ruiz, Allison Lee
    IEEE TRANSACTIONS ON PROFESSIONAL COMMUNICATION, 2020, 63 (03) : 275 - 276
  • [8] Shaping the future of cardiovascular medicine in the new era of wearable devices
    Gehr, Sinje
    Russmann, Christoph
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (08) : 501 - 502
  • [9] Shaping the future of cardiovascular medicine in the new era of wearable devices
    Sinje Gehr
    Christoph Russmann
    Nature Reviews Cardiology, 2022, 19 : 501 - 502
  • [10] Pharmacogenomics, precision medicine, and implications for anesthesia care
    Kaye, Alan D.
    Mahakian, Thomas
    Kaye, Aaron J.
    Pham, Andrew A.
    Hart, Brendon M.
    Gennuso, Sonja
    Cornett, Elyse M.
    Gabriel, Rodney A.
    Urman, Richard D.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2018, 32 (02) : 61 - 81